About Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc. engages in the development of pharmaceutical solutions for common addictions and related disorders. It focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. Opiant Pharmaceuticals was founded on June 21, 2005 and is headquartered in Santa Monica, CA.

At the moment the company generates 39M USD in revenues.

On its last earning announcement, the company reported a profit of 2.21$ per share.

The book value per share is 2.97$

Opiant Pharmaceuticals, Inc. website

Create a solid portfolio with OPNT

Add OPNT to your portfolio and optimize it!


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
39M 78.80% 11M 28.00% 12M 2.21 - - 5M 2.97 6M - 6M